HCV - Insulin Resistance / Diabetes
Obesity and Diabetes Are Linked to Increased Risk of Liver Cancer - 7/18/08Insulin Resistance and Diabetes Increase the Risk of Liver Fibrosis and Hepatocellular Carcinoma in People with Chronic Hepatitis C - 7/04/08Sustained Response to Interferon-based Therapy Reduces the Likelihood of Type 2 Diabetes - 6/24/08 Insulin Resistance and Diabetes Increase the Risk of Liver Fibrosis and Hepatocellular Carcinoma in People with Chronic Hepatitis C - 6/24/08 Sustained Response to Interferon-based Therapy Reduces the Likelihood of Type 2 Diabetes - 6/24/08 Insulin Resistance is a Risk Factor for Liver Fibrosis Even without Steatosis - 2/29/08 Insulin Resistance Linked to Lower Treatment Response in Genotype 2/3 Patients - 2/01/08 Community-based Study in Taiwan Provides More Evidence of Link between Hepatitis C and Type 2 Diabetes - 8/17/07Insulin Resistance and Liver Injury in Hepatitis C Patients Are Not Associated with Virus-Specific Changes in Adipocytokines - 7/17/07 Hepatitis C Viremia, but Not Hepatitis B, Is Associated with Increased Diabetes Risk - 7/17/07Diabetes Treatment May Improve Response to Pegylated Interferon/Ribavirin, and HCV Eradication in Turn May Reduce Insulin Resistance - 6/19/07 Diabetes is Associated with Hepatic Encephalopathy in Patients with HCV-Related Cirrhosis- 8/18/06
More Evidence that Hepatitis C Virus Infection is Associated with Insulin Resistance 2/23/07
HCV Clearance Improves Insulin Resistance 2/06/07
Impact and Management of Insulin Resistance in Patients with Hepatitis C 12/12/06
FDA-approved Combination Therapies for Chronic HCV Infection
Pegasys + Copegus PEG-Intron + Rebetol Intron A + Rebetol Roferon A + Ribavirin Treatment Guidelines
HCV Articles by Topic
HCV Liver Issues Cirrhosis Fibrosis Hepatocellular Carcinoma Liver Transplantation Liver Biopsy Steatosis